Reading Time: 2 minutes
Ceribell (CBLL) I now expect to reach an all-time high. The medical technology company develops a portable EEG system for rapid diagnosis and continuous monitoring of neurological disorders at the bedside. The focus is on AI-supported detection of non-convulsive status epilepticus (NCSE), which is often only visible in the EEG without obvious seizures. I appreciate that Ceribell not only provides quickly deployable single-use headbands but also the accompanying AI software, Clarity AI, for real-time data analysis, with recurring revenues increasing...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

